Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,438 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Chemical and biological investigations of beta-oligoarginines.
Seebach D, Namoto K, Mahajan YR, Bindschädler P, Sustmann R, Kirsch M, Ryder NS, Weiss M, Sauer M, Roth C, Werner S, Beer HD, Munding C, Walde P, Voser M. Seebach D, et al. Among authors: sauer m. Chem Biodivers. 2004 Jan;1(1):65-97. doi: 10.1002/cbdv.200490014. Chem Biodivers. 2004. PMID: 17191776
Cellular uptake studies with beta-peptides.
Rueping M, Mahajan Y, Sauer M, Seebach D. Rueping M, et al. Among authors: sauer m. Chembiochem. 2002 Mar 1;3(2-3):257-9. doi: 10.1002/1439-7633(20020301)3:2/3<257::AID-CBIC257>3.0.CO;2-S. Chembiochem. 2002. PMID: 11921409 No abstract available.
The course of physical fitness and nutritional status in patients following prehabilitation before esophageal cancer surgery: Results from the PRIOR study.
Reijneveld EAE, Kooij CD, Dronkers JJ, Kingma BF, Stel JMA, Sauer M, van Hillegersberg R, van Duijvendijk P, Beijer S, Ruurda JP, Veenhof C; ‘PRIOR study group’. Reijneveld EAE, et al. Among authors: sauer m. Eur J Surg Oncol. 2025 Jan 3;51(3):109575. doi: 10.1016/j.ejso.2025.109575. Online ahead of print. Eur J Surg Oncol. 2025. PMID: 39813770 Free article.
Betibeglogene autotemcel gene therapy in patients with transfusion-dependent, severe genotype β-thalassaemia (HGB-212): a non-randomised, multicentre, single-arm, open-label, single-dose, phase 3 trial.
Kwiatkowski JL, Walters MC, Hongeng S, Yannaki E, Kulozik AE, Kunz JB, Sauer MG, Thrasher AJ, Thuret I, Lal A, Tao G, Ali S, Thakar HL, Elliot H, Lodaya A, Lee J, Colvin RA, Locatelli F, Thompson AA. Kwiatkowski JL, et al. Among authors: sauer mg. Lancet. 2024 Nov 30;404(10468):2175-2186. doi: 10.1016/S0140-6736(24)01884-1. Epub 2024 Nov 8. Lancet. 2024. PMID: 39527960 Clinical Trial.
1,438 results